These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11270479)

  • 1. Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia.
    Lissoni P; Bucovec R; Bonfanti A; Giani L; Mandelli A; Roselli MG; Rovelli F; Fumagalli L
    J Pineal Res; 2001 Mar; 30(2):123-6. PubMed ID: 11270479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients.
    Lissoni P; Malugani F; Bukovec R; Bordin V; Perego M; Mengo S; Ardizzoia A; Tancini G
    Neuro Endocrinol Lett; 2003; 24(1-2):83-5. PubMed ID: 12743539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer as the main aging factor for humans: the fundamental role of 5-methoxy-tryptamine in reversal of cancer-induced aging processes in metabolic and immune reactions by non-melatonin pineal hormones.
    Lissoni P; Messina G; Rovelli F
    Curr Aging Sci; 2012 Dec; 5(3):231-5. PubMed ID: 23451999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia.
    Lissoni P; Tancini G; Barni S; Paolorossi F; Rossini F; Maffé P; Di Bella L
    Recenti Prog Med; 1996 Dec; 87(12):582-5. PubMed ID: 9066251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study.
    Lissoni P; Tancini G; Paolorossi F; Mandalà M; Ardizzoia A; Malugani F; Giani L; Barni S
    J Pineal Res; 1999 Apr; 26(3):169-73. PubMed ID: 10231730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytryptophol in the treatment of human neoplasms.
    Lissoni P
    Ann N Y Acad Sci; 2000; 917():560-7. PubMed ID: 11268384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone.
    Lissoni P; Rovelli F; Frassineti A; Fumagalli L; Malysheva O; Conti A; Maestroni G
    Neuro Endocrinol Lett; 2000; 21(4):319-323. PubMed ID: 11455367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.
    Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G
    Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia.
    Lissoni P; Barni S; Brivio F; Rossini F; Fumagalli L; Ardizzoia A; Tancini G
    Oncology; 1995; 52(5):360-2. PubMed ID: 7637951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II study.
    Lissoni P; Barni S; Brivio F; Rossini F; Fumagalli L; Tancini G
    J Biol Regul Homeost Agents; 1995; 9(2):52-4. PubMed ID: 9127633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatonin.
    Bregani ER; Lissoni P; Rossini F; Barni S; Tancini G; Brivio F; Conti A; Maestroni GJ
    Recenti Prog Med; 1995 Jun; 86(6):231-3. PubMed ID: 7624582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth Factors: Thrombopoietic Property of the Pineal Hormone Melatonin.
    Lissoni P; Mandala M; Rossini F; Fumagalli L; Barni S
    Hematology; 1999; 4(4):335-343. PubMed ID: 11399574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone.
    Lissoni P; Cazzaniga M; Tancini G; Scardino E; Musci R; Barni S; Maffezzini M; Meroni T; Rocco F; Conti A; Maestroni G
    Eur Urol; 1997; 31(2):178-81. PubMed ID: 9076462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of tryptophan derivatives to mimic melatonin's action upon the Syrian hamster reproductive system.
    Rollag MD
    Life Sci; 1982 Dec; 31(24):2699-707. PubMed ID: 6961276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.
    Lissoni P; Giani L; Zerbini S; Trabattoni P; Rovelli F
    Nat Immun; 1998; 16(1):27-33. PubMed ID: 9789122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
    Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin.
    Lissoni P; Fumagalli L; Paolorossi F; Rovelli F; Roselli MG; Maestroni GJ
    J Biol Regul Homeost Agents; 1997; 11(3):119-22. PubMed ID: 9498162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status.
    Lissoni P; Barni S; Mandalà M; Ardizzoia A; Paolorossi F; Vaghi M; Longarini R; Malugani F; Tancini G
    Eur J Cancer; 1999 Nov; 35(12):1688-92. PubMed ID: 10674014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.